BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25840050)

  • 1. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.
    Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G
    Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
    Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
    Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
    Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
    Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCCA antigen combined with alpha-fetoprotein as serologic markers of HCC.
    Giannelli G; Marinosci F; Trerotoli P; Volpe A; Quaranta M; Dentico P; Antonaci S
    Int J Cancer; 2005 Nov; 117(3):506-9. PubMed ID: 15906357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
    Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
    Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
    Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
    Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
    Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
    Teofănescu I; Gologan E; Stefănescu G; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu J; Wang ZJ; Chen LH; Dong WZ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
    Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
    Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
    Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
    PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
    Giannelli G; Fransvea E; Trerotoli P; Beaugrand M; Marinosci F; Lupo L; Nkontchou G; Dentico P; Antonaci S
    Clin Chim Acta; 2007 Aug; 383(1-2):147-52. PubMed ID: 17582392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.